Phenelzine for chronic depression: a study of continuation treatment
- PMID: 3522558
Phenelzine for chronic depression: a study of continuation treatment
Abstract
Several controlled studies have demonstrated the efficacy of continuation therapy with tricyclic antidepressants, but little is known about continuation therapy with the monoamine oxidase inhibitors. Moreover, the usefulness of continuation antidepressant therapy in patients with chronic depressive disorders has not been evaluated. This pilot study reports initial results of a double-blind continuation trial of phenelzine or placebo following an initial antidepressant response to phenelzine in 12 patients who met DSM-III criteria for dysthymic disorder. All 7 patients randomized to placebo relapsed, whereas only 1 of the 5 patients who continued to receive phenelzine relapsed. These results suggest that continuation therapy with phenelzine may be useful in maintaining clinical response after acute treatment.
Similar articles
-
Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.J Psychiatry Neurosci. 1997 Mar;22(2):127-31. J Psychiatry Neurosci. 1997. PMID: 9074307 Free PMC article. Review.
-
Efficacy in long-term treatment of depression.J Clin Psychiatry. 1996;57 Suppl 2:24-30. J Clin Psychiatry. 1996. PMID: 8626360 Review.
-
Chronic depression: response to placebo, imipramine, and phenelzine.J Clin Psychopharmacol. 1993 Dec;13(6):391-6. J Clin Psychopharmacol. 1993. PMID: 8120152 Clinical Trial.
-
Phenelzine treatment of melancholia.J Clin Psychiatry. 1986 Aug;47(8):420-2. J Clin Psychiatry. 1986. PMID: 3525522 Clinical Trial.
-
Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study.Psychopharmacol Bull. 1991;27(1):31-9. Psychopharmacol Bull. 1991. PMID: 1862204 Clinical Trial.
Cited by
-
Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults.Cochrane Database Syst Rev. 2021 Apr 15;4(4):CD013495. doi: 10.1002/14651858.CD013495.pub2. Cochrane Database Syst Rev. 2021. PMID: 33886130 Free PMC article.
-
Comparative effectiveness of continuation and maintenance treatments for persistent depressive disorder in adults.Cochrane Database Syst Rev. 2019 May 20;5(5):CD012855. doi: 10.1002/14651858.CD012855.pub2. Cochrane Database Syst Rev. 2019. PMID: 31106850 Free PMC article.
-
Prevention of Relapse and Recurrence in Adults with Major Depressive Disorder: Systematic Review and Meta-Analyses of Controlled Trials.Int J Neuropsychopharmacol. 2015 Jul 7;19(2):pyv076. doi: 10.1093/ijnp/pyv076. Int J Neuropsychopharmacol. 2015. PMID: 26152228 Free PMC article. Review.
-
Current Perspectives on the Diagnosis and Treatment of Double Depression.CNS Drugs. 1996 May;5(5):344-57. doi: 10.2165/00023210-199605050-00004. CNS Drugs. 1996. PMID: 26071047
-
Blue again: perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression.Front Psychol. 2011 Jul 7;2:159. doi: 10.3389/fpsyg.2011.00159. eCollection 2011. Front Psychol. 2011. PMID: 21779273 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous